Hillary Clinton is finally getting a little love from Big Pharma.
The head of the Pharmaceutical Research and Manufacturers of America (PhRMA) told The Hill that his group supports the policy floated by the leading Democratic presidential candidate, which would cap an individual’s monthly out-of-pocket prescription drug spending at $250.
“I would say one thing that she has proposed that we would favor is capping out-of-pocket costs,” PhRMA CEO Stephen Ubl said. “I think we have to acknowledge that some patients do face challenges in accessing their medicines.”
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
